Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S367000, C544S133000, C544S295000, C544S357000, C546S209000, C548S131000, C548S204000, C548S236000
Reexamination Certificate
active
11550060
ABSTRACT:
The present invention provides a compound of formula (I):wherein R1–R5, R25, R26, Y and X2are as defined herein. The compounds activate human peroxisome proliferator activated receptors (hPPARs) and are useful for the treatment of associated disorders such as cardiovascular disease and hypercholesteremia.
REFERENCES:
patent: 5972881 (1999-10-01), Heyman et al.
patent: 2004/0077659 (2004-04-01), Oliver, Jr.
patent: 00/08002 (2000-02-01), None
patent: 02/062774 (2000-08-01), None
patent: 01/00603 (2001-01-01), None
patent: 01/40207 (2001-06-01), None
patent: 02/50048 (2002-06-01), None
J.M. Lehmann et al., “An Antidiabetic Thiazolidinedione is a High Affinity Ligand for Peroxisome Proliferator-Activated Receptor Gamma,”Journal of Biological Chemistry, V270, N22, Jun. 2, 1995, pp. 12953-12956.
W.R. Oliver et al., “A Selective Peroxisome Proliferator-Activated Receptor Delta Agonist Promotes Reverse Cholesterol Transport,”Proceeding of the National Academy of Sciences of the USA, V98, N9, Apr. 24, 2001, pp. 5306-5311.
Ellis et al., “Troglitazone Improves Psoriasis and Normalizes Models of Proliferative Skin Disease,”Arch Dermatol, V136, May 2000, pp. 609-616.
Vippagunta et al., Advanced Drug Delivery Reviews, 2000, V48, pp. 3-26.
Mae et al., American Society for Nutritional Sciences, 2003, 99 3369-3377.
Berger et al., Annu. Rev. Med., 2002, V53, pp. 409-435.
Miyachi, Expert Opin. Ther. Patents, 2004, V14, pp. 607-618.
Rami et al., Exp. Opin. Ther. Patents, 2000, V10, pp. 623-634.
Mukherjee et al., Emerging Therapeutic Targerts, 2000, V4, pp. 377-396.
Bishop-Bailey, British Journal of Pharmacology, 2000, V129, pp. 823-834.
Cadilla Rodolfo
Lambert, III Millard Hurst
Rafferty Stephen William
Sternbach Daniel David
Bernhardt Emily
Fox Jennifer L.
SmithKline Beecham Corporation
LandOfFree
Thiazole and oxazole derivatives as activators of human... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole and oxazole derivatives as activators of human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole and oxazole derivatives as activators of human... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3827934